2.0
8 Aug 2024
Former contractor, less than 1 year
Recommend
CEO approval
Business outlook
Pros
Can't think of anything at this time.
Cons
This company acquired Fluxion Biosciences and ran it into the ground. Subsequently, there's been a massive exodus—the company likely has less than 6 months of runway